effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
Published 1 year ago • 51 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
1:56
axillary management for breast cancer in the post-neoadjuvant setting
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
1:24
detection of ctdna post neoadjuvant chemo is associated with disease relapse in early breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
8:52
real-world outcomes of her2 and tnbc patients recieving neoadjuvant chemotherapy
-
5:34
neos: prognosis of er breast cancer pts who received neoadjuvant et with/without adjuvant chemo
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:38
compassher2-pcr: de-escalation of neoadjuvant chemotherapy for breast cancer
-
2:55
systemic immune response to durvalumab concomitant with neoadjuvant chemotherapy in early stage tncb
-
1:45
association of pathologic complete response following neoadjuvant chemotherapy with longterm sur...
-
1:16
state of the art of surgery in patients with early breast cancer
-
1:43
the role of the checkpoint inhibitors in breast cancer
-
7:15
characterizing the immune microenvironment before and following anti-her2 neoadjuvant therapy
-
2:52
opacin-neo trial rfs and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
1:58
promising novel approaches to the treatment of tnbc
-
1:34
axillary surgery trends in breast cancer after neoadjuvant treatment